FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: While not directly industry-specific, the approval of an mRNA flu vaccine could influence public health initiatives and vaccine distribution strategies statewide, potentially impacting how the South Carolina Department of Health and Environmental Control plans for future flu seasons.

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.